siRNA treatment lowers triglycerides in patients with rare condition

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride levels through 80% and also decreased the danger of pancreatitis in people with chronic chylomicronemia, along with or even without a genetic prognosis.